Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukaemia (Acute)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01200355
What this trial is testing

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center 113
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT03820908
What this trial is testing

Bisantrene for Relapsed /Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaAllogeneic Stem Cell Transplantation
Sheba Medical Center 10
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Early research (Phase 1)Study completedNCT03042689
What this trial is testing

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07425808
What this trial is testing

FLT3-ITD Targeted Therapy in Fit AML Patients

Who this might be right for
AML (Acute Myeloid Leukemia)
European Organisation for Research and Treatment of Cancer - EORTC 230
Early research (Phase 1)WithdrawnNCT04655391
What this trial is testing

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Who this might be right for
Recurrent Acute Myeloid Leukemia
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00606723
What this trial is testing

Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Hannover Medical School 154
Testing effectiveness (Phase 2)Study completedNCT05120570
What this trial is testing

PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more
Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)Study completedNCT02834390
What this trial is testing

Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Daiichi Sankyo Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT00008697
What this trial is testing

Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia

Who this might be right for
Leukemia
Washington University School of Medicine 13
Early research (Phase 1)Looking for participantsNCT06879340
What this trial is testing

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

Who this might be right for
B-Cell Non-Hodgkin LymphomaB-cell Acute Lymphoblastic Leukemia
University of Kansas Medical Center 54
Testing effectiveness (Phase 2)UnknownNCT02851589
What this trial is testing

Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Who this might be right for
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT01106950
What this trial is testing

Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)

Who this might be right for
Leukemia, Myelogenous, Acute
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Study completedNCT03559413
What this trial is testing

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Who this might be right for
Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults
University Children's Hospital Tuebingen 30
Large-scale testing (Phase 3)Study completedNCT00866918
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia

Who this might be right for
Childhood Acute Promyelocytic Leukemia With PML-RARAMyeloid Neoplasm
Children's Oncology Group 106
Not applicableStudy completedNCT06338020
What this trial is testing

Adaptive Variable-Resistance Training in Pediatric Survivors of Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Cairo University 62
Early research (Phase 1)Temporarily pausedNCT06802523
What this trial is testing

Testing the Combination of Targeted Radiotherapy With Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 53
Not applicableEnded earlyNCT04006496
What this trial is testing

AML Expressive Writing

Who this might be right for
Acute Myeloid Leukemia
Duke University 15
Early research (Phase 1)Study completedNCT00878189
What this trial is testing

A Trial In Patients With Advanced Cancer And Leukemia

Who this might be right for
Neoplasms by Histologic Type
Pfizer 72
Next Page